Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Dian Diagnostics In-licenses Metabolon’s Metabolomics Platform

publication date: Feb 7, 2017

Zhejiang Dian Diagnostics, one of China’s largest chains of independent medical laboratories, has entered into a joint laboratory licensing agreement with Metabolon, a metabolomics company based in North Carolina. Under the terms of the agreement, Dian will install Metabolon’s proprietary Discovery HD4™ platform in its new, state-of-the-art laboratory in Hangzhou and use its extensive market presence to commercialize Metabolon’s metabolomics-based products and services throughout China. Financial and other terms of the agreement were not disclosed. More details....

Stock Symbol (SHE: 300244)



Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital